Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Randy Swan of Swan Wealth Advisors launches Swan Re

Friday, December 20, 2013

Bailey McCann, Opalesque New York:

Randy Swan and the team at Swan Wealth Advisors might not jump to mind when you start thinking about asset managers, but they probably should. Since 1997 the firm has run a strategy that eschews a lot of exotic overlays and market timing to provide consistent performance. Once a group of private separately managed accounts, the team moved into the retail space by offering a mutual fund that relies on its core strategy.

Now, Swan is expanding again, this time into reinsurance.

In a way, adding a reinsurance offering will take Swan back to his roots. Before opening Swan Wealth Advisors, Randy worked at KPMG as a senior manager in the Financial Services Group focusing on insurance companies and working with risk managers. He came to reinsurance through a relationship with the principals at MultiStrat Re, a reinsurance platform backed by Taussig Capital and Middlebury Securities. Opalesque previously reported on the launch of the MultiStrat Re platform, Swan’s reinsurance company – SwanRe represents the expansion phase of MultiStrat. (Refer to our exclusive coverage for an in-depth view of the platform.)

Swan is poised to be one of the foundational reinsurers on the platform by backing Swan Re with the flagship Swan Defined Risk Strategy of its mutual funds and managed accounts. The Defined Risk Strategy is a......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner